Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
Public ClinicalTrials.gov record NCT01147939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised Phase III Study of Elacytarabine vs. Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to assess the efficacy and safety of elacytarabine versus investigator's choice treatment in patients with relapsed or refractory acute myeloid leukemia (AML).
Study identification
- NCT ID
- NCT01147939
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 381 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2010 (Type not available)
- Primary completion
- Feb 2013 (Actual)
- Completion
- Jun 2013 (Actual)
- Last update posted
- Sep 27, 2013
2010 – 2013
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Cancer Center Clinical Research | La Jolla | California | 90095 | — |
| USC/Norris Comprehensive Cancer Center and Hospital | Los Angeles | California | 90033 | — |
| UCLA School of Medicine, Division of Hematology/Oncology | Los Angeles | California | 90095 | — |
| Rocky Mountain Blood and Bone Marrow Transplant Program | Denver | Colorado | 80218 | — |
| Shands at the University of Florida | Gainesville | Florida | 32610 | — |
| Winship Cancer Institute at Emory | Atlanta | Georgia | 30322 | — |
| The Blood and Marrow Transplant Group of GA | Atlanta | Georgia | 30342 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| St. Francis Hospital and Health Center | Indianapolis | Indiana | 46107 | — |
| University of Iowa Hopsitals | Iowa City | Iowa | 52242 | — |
| LSU Health Sciences Center, | Shreveport | Louisiana | 71103 | — |
| Northern New Jersey Cancer Associates | Hackensack | New Jersey | 07601 | — |
| New York Presbyterian Hospital, Weill-Cornell Medical College | New York | New York | 10021 | — |
| Memorial Sloan-Kettering | New York | New York | 10065 | — |
| New York Medical College | Valhalla | New York | 10595 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Wake Forest University, Health Sciences Section on Hematology and Oncology | Winston-Salem | North Carolina | 27157-1082 | — |
| The Jewish Hospital | Cincinnati | Ohio | 45236 | — |
| Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| St. Francis Hospital | Greenville | South Carolina | 29601 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Froedtert Hospital, Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01147939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2013 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01147939 live on ClinicalTrials.gov.